Prominent Florida eye doctor acquitted of Medicare fraud in billing for cancer treatments [Miami Herald]
A prominent
Dr.
“The jurors came out of the courthouse, shook our hands and said, ‘You made it very easy for us,’ “ Rosecan’s defense attorney,
At trial, federal prosecutors tried to prove that Rosecan falsely diagnosed eight patients with choroidal melanoma, a tumor of the eye originating in the choroid, which is a vascular layer of tissue located behind the retina. Prosecutor
In total, according to an indictment, Rosecan was accused of falsely billing about
But the
Rosecan, who received a B.A. degree in molecular biophysics and biochemistry from
Rubio, who worked on Rosecan’s defense with attorney
The case against Rosecan was filed during the depths of the pandemic, with the clock ticking on the statute of limitations.
In March of 2021, Ruiz denied Rosecan’s dismissal motion and sided with the prosecutors, citing the specific language of the federal statute of limitations. To wit: “Except as otherwise expressly provided by law, no person shall be prosecuted, tried, or punished for any offense, not capital, unless the indictment is found or the information is instituted within five years next after such offense shall have been committed.”
In other words, Ruiz concluded that the prosecutors acted lawfully because they “instituted,” or began, the process of prosecuting the physician by information, saying it is allowable under the statute of limitations dating back to the 1790 Crimes Act.
In the end, the judge’s initial ruling didn’t matter. The prosecutors eventually obtained a grand jury indictment in 2021 and lost their case against Rosecan this week.
©2022 Miami Herald. Visit miamiherald.com. Distributed by Tribune Content Agency, LLC.



The American Bar Association (ABA) – Discussion
Prominent Florida eye doctor acquitted of Medicare fraud in billing for cancer treatments [Miami Herald]
Advisor News
- Geopolitical instability and risk raise fears of Black Swan scenarios
- Structured Note Investors Recover $1.28M FINRA Award Against Fidelity
- Market reports turn economic trends into a strategic edge for advisors
- SEC in ‘active and detailed’ settlement talks with accused scammer Tai Lopez
- Sketching out the golden years: new book tries to make retirement planning fun
More Advisor NewsAnnuity News
- Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
- Rethinking whether annuities are too late for older retirees
- Advising clients wanting to retire early: how annuities can bridge the gap
- F&G joins Voya’s annuity platform
- Regulators ponder how to tamp down annuity illustrations as high as 27%
More Annuity NewsHealth/Employee Benefits News
- PID finds violations by Aetna Insurance
- Iowa insurance firms warn bill would make health costs rise
- ELLMAN BILL PROTECTS ACCESS TO HEALTH COVERAGE, PREVENTS DENIALS OVER PAST-DUE PREMIUMS
- Blue Cross Blue Shield of Wyoming CEO Gore announces retirement; Urbanek to take lead
- Wellpoint taps Rachel Chinetti as president
More Health/Employee Benefits NewsLife Insurance News
- Jackson Earns Award for Highest Customer Service in Financial Industry for 14th Consecutive Year
- Annexus and Americo Announce Strategic Partnership with Launch of Americo Benchmark Flex Fixed Indexed Annuity Suite
- LIMRA: Individual life insurance new premium sets 2025 sales record
- How AI can drive and bridge the insurance skills gap
- Symetra Partners With Empathy to Offer Bereavement Support to Group Life Insurance Beneficiaries
More Life Insurance News